Bank of America’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $649M | Sell |
|
|||||
|
2025
Q2 | $641M | Buy |
|
|||||
|
2025
Q1 | $662M | Buy |
|
|||||
|
2024
Q4 | $670M | Sell |
|
|||||
|
2024
Q3 | $1.04B | Buy |
|
|||||
|
2024
Q2 | $1.02B | Buy |
|
|||||
|
2024
Q1 | $851M | Buy |
|
|||||
|
2023
Q4 | $772M | Buy |
|
|||||
|
2023
Q3 | $689M | Sell |
|
|||||
|
2023
Q2 | $603M | Sell |
|
|||||
|
2023
Q1 | $778M | Buy |
|
|||||
|
2022
Q4 | $645M | Sell |
|
|||||
|
2022
Q3 | $722M | Sell |
|
|||||
|
2022
Q2 | $628M | Sell |
|
|||||
|
2022
Q1 | $803M | Sell |
|
|||||
|
2021
Q4 | $733M | Buy |
|
|||||
|
2021
Q3 | $700M | Buy |
|
|||||
|
2021
Q2 | $623M | Sell |
|
|||||
|
2021
Q1 | $558M | Buy |
|
|||||
|
2020
Q4 | $537M | Sell |
|
|||||
|
2020
Q3 | $677M | Sell |
|
|||||
|
2020
Q2 | $777M | Buy |
|
|||||
|
2020
Q1 | $580M | Buy |
|
|||||
|
2019
Q4 | $424M | Buy |
|
|||||
|
2019
Q3 | $308M | Sell |
|
|||||
|
2019
Q2 | $356M | Sell |
|
|||||
|
2019
Q1 | $511M | Sell |
|
|||||
|
2018
Q4 | $466M | Buy |
|
|||||
|
2018
Q3 | $500M | Sell |
|
|||||
|
2018
Q2 | $449M | Buy |
|
|||||
|
2018
Q1 | $407M | Buy |
|
|||||
|
2017
Q4 | $357M | Sell |
|
|||||
|
2017
Q3 | $720M | Buy |
|
|||||
|
2017
Q2 | $552M | Buy |
|
|||||
|
2017
Q1 | $426M | Buy |
|
|||||
|
2016
Q4 | $365M | Buy |
|
|||||
|
2016
Q3 | $347M | Buy |
|
|||||
|
2016
Q2 | $224M | Buy |
|
|||||
|
2016
Q1 | $184M | Sell |
|
|||||
|
2015
Q4 | $353M | Buy |
|
|||||
|
2015
Q3 | $259M | Buy |
|
|||||
|
2015
Q2 | $222M | Buy |
|
|||||
|
2015
Q1 | $195M | Sell |
|
|||||
|
2014
Q4 | $188M | Sell |
|
|||||
|
2014
Q3 | $199M | Sell |
|
|||||
|
2014
Q2 | $186M | Sell |
|
|||||
|
2014
Q1 | $228M | Buy |
|
|||||
|
2013
Q4 | $203M | Buy |
|
|||||
|
2013
Q3 | $202M | Buy |
|
|||||
|
2013
Q2 | $136M | Buy |
|